APA (7th ed.) Citation

Y, M., Y, T., T, Y., & K, M. (2026). Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: A post-marketing surveillance study in Japan. International journal of hematology, 124(4), 502. https://doi.org/10.1007/s12185-026-04227-w

Chicago Style (17th ed.) Citation

Y, Morita, Tsuji Y, Yasukawa T, and Mitani K. "Darbepoetin Alfa for the Treatment of Anemia in Myelodysplastic Syndromes: A Post-marketing Surveillance Study in Japan." International Journal of Hematology 124, no. 4 (2026): 502. https://doi.org/10.1007/s12185-026-04227-w.

MLA (9th ed.) Citation

Y, Morita, et al. "Darbepoetin Alfa for the Treatment of Anemia in Myelodysplastic Syndromes: A Post-marketing Surveillance Study in Japan." International Journal of Hematology, vol. 124, no. 4, 2026, p. 502, https://doi.org/10.1007/s12185-026-04227-w.